Tissue Additives News
New brochure "TEGOPREN® for tissue, pulp and paper"
A new brochure about our TEGOPREN® product portfolio for tissue, pulp and paper is now available.
Our outstanding application and process expertise is based on a broad technology platform of organic specialty surfactants and organomodified siloxanes. Our product range covers a variety of products with specific application profiles, which address almost all needs of the tissue and fluff pulp industry: softeners and debonders under the AROSURF®, VARISOFT®, and REWOQUAT® trade names as
well as softeners and pulp and paper defoamers under the TEGOPREN® trade name.
In addition to their pronounced surfactant properties in aqueous and organic systems TEGOPREN® products are primarily characterized by their multifunctionality. Their properties include levelling, wetting and dewetting, releasing and/or debonding, foaming or defoaming, emulsifying or demulsifying and dispersing or coagulating.
The brochure offers a good overview about applications fields and benefits of our TEGOPREN® product portoflio.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals, operating in the Nutrition & Care, Resource Efficiency and Performance Materials segments. The company benefits from its innovative prowess and integrated technology platforms. In 2015 more than 33,500 employees generated sales of around €13.5 billion and an operating profit (adjusted EBITDA) of about €2.47 billion.
The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 7,000 employees, and generated sales of around €4.9 billion in 2015.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.